MG
EDVA

Mather Group’s Endovia Health Sciences, Inc. EDVA Stock Holding History

Mather Group’s Portfolio EDVA Stock Details EDVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-28
Closed -$155 – 1510
2025
Q1 		$155 Hold
28
– – ﹤0.01% 1744
2024
Q4 		$719 Hold
28
– – ﹤0.01% 1633
2024
Q3 		$1.13K Hold
28
– – ﹤0.01% 1548
2024
Q2 		$2.05K Hold
28
– – ﹤0.01% 1883
2024
Q1 		$2.47K Buy
+28
New +$2.23K ﹤0.01% 1506

Other funds holding EDVA

CL
Choreo LLC Rockford, Illinois $9.11B AUM 26.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

Mather Group's EDVA Position: Q2 2025 in Review

Mather Group sold out of Endovia Health Sciences, Inc. (EDVA) in Q2 2025, closing a stake of 28 shares — an estimated $155 sold.

Mather Group first reported a position in EDVA in Q1 2024 and held it in 5 quarters. The position peaked at $2.47K in Q1 2024. 12 funds tracked by Wall St. Rank hold EDVA as of Q2 2025.

  • Mather Group reported no remaining Endovia Health Sciences, Inc. position as of Q2 2025 after selling out during the quarter.
  • Mather Group sold 28 Endovia Health Sciences, Inc. shares in Q2 2025, an estimated $155.
  • Mather Group first reported a position in Endovia Health Sciences, Inc. in Q1 2024 and held it in 5 quarters.
  • Mather Group's Endovia Health Sciences, Inc. position peaked at $2.47K in Q1 2024.
  • 12 funds tracked by Wall St. Rank held Endovia Health Sciences, Inc. as of Q2 2025.

Based on Mather Group's 13F filing for Q2 2025, filed 15 Jul 2025.